PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Dirk Görlich receives Louis-Jeantet Prize for Medicine 2024

The scientist investigates how large molecules are transported between the cell nucleus and cytoplasm

Dirk Görlich receives Louis-Jeantet Prize for Medicine 2024
2024-01-23
(Press-News.org)

The Louis-Jeantet Foundation honors the Director at the Max Planck Institute (MPI) for Multidisciplinary Sciences for discovering a new kind of biological matter that acts as a highly selective barrier to control central transport pathways in the cell. He has made groundbreaking contributions to our understanding of the processes by which macromolecules are transported into and out of the cell nucleus, the foundation said. The prestigious award is endowed with 500,000 Swiss francs (around 537,000 euros).

Görlich studies how cells solve the logistical challenge of getting their proteins to the right place. This includes importing thousands of different proteins into the cell nucleus but also keeping many others outside. This sorting is accomplished by one of nature’s most efficient protein transport machines, so-called nuclear pore complexes (NPCs) that are embedded into the envelope of the nucleus.

NPCs feature a mysterious functional duality: They are rather impermeable to most macromolecules. However, certain “transporters” called importins and exportins are literally sucked into the central NPC channel and released again on the other side. This can happen very fast – up to a thousand times per pore per second. Görlich’s team was instrumental in discovering and analyzing these transporters.  They capture macromolecular cargoes and either deliver them into the nucleus or export them from cell nuclei.

“Intelligent” barrier at the cell nucleus

Görlich and his team have discovered a remarkable material, the “FG phase” that is key to the powerful transport function of NPCs. This material is a “condensate” of so-called FG repeat domains – disordered but typically cohesive (sticky) regions of certain nucleoporins. The jelly-like FG phase acts as an “intelligent” barrier, filling the central channel of nuclear pores and sorting macromolecules. It repels unwanted macromolecules but is a good “solvent” and transport medium for importins and exportins together with their cargo. Where the transporter binds to an FG repeat, FG meshes transiently disengage; the transporter and its cargo can glide through the jelly. As they pass through, the meshes close again behind the transporter.

“The FG phase initially appeared to be an exotic form of biological matter. However, we now know that it represents a general principle in living cells. It was just a first example of a wide range of cellular condensates that form in a similar way and function as ‘mini-laboratories’ to coordinate and regulate biochemical reactions. The Louis-Jeantet Prize is a wonderful recognition for our entire team after many years of joint research,” said the prize winner.

 Opening up a new field of research

“The transport of macromolecules between cytoplasm and nucleus is fundamental for eukaryotic life and also highly relevant for disease,” says Holger Stark, Managing Director of the MPI for Multidisciplinary Sciences. Dirk Görlich was the first to explain how molecular transporters and the FG phase work together as a highly efficient “pump” for macromolecules. “With the discovery of the FG phase, he has opened up a completely new field of research. We are delighted that our colleague has been honored with this well-deserved award.”

After Bert Sakmann, Peter Gruss, Herbert Jäckle, and Patrick Cramer, Dirk Görlich is the fifth scientist at the MPI for Multidisciplinary Sciences to receive this award.

About the award winner

Dirk Görlich studied biochemistry in Halle and completed his doctoral thesis at the Max Delbrück Center for Molecular Medicine in Berlin. After a two-year research stay at the Wellcome / CRC Institute (now the Gurdon Institute) in Cambridge (United Kingdom), he was appointed research group leader in 1996 and Professor of Molecular Biology at the Center for Molecular Biology at Heidelberg University in 2001. Since 2007, he has headed the Department of Cellular Logistics at the MPI for Multidisciplinary Sciences (until 31.12.2021: MPI for Biophysical Chemistry). Dirk Görlich has received numerous scientific awards, including the Heinz Maier-Leibnitz Prize, the EMBO Gold Medal, the Alfried Krupp Prize, the WLA Prize 2022, and the Animal Welfare Research Prize of the Federal Ministry of Food and Agriculture. He is a member of the European Molecular Biology Organization (EMBO) and the German National Academy of Sciences Leopoldina.

About the Louis-Jeantet Prize

The Louis-Jeantet Prizes were first awarded in 1986. Since then, up to three prizes have been awarded each year to researchers working in the field of biomedicine in one of the member states of the Council of Europe. The award recognizes completed work and is intended to support future innovative research projects by the prize winners.

Further information

https://www.jeantet.ch/en/ - Website of the Louis-Jeantet Foundation (in English and French)

END


[Attachments] See images for this press release:
Dirk Görlich receives Louis-Jeantet Prize for Medicine 2024 Dirk Görlich receives Louis-Jeantet Prize for Medicine 2024 2

ELSE PRESS RELEASES FROM THIS DATE:

Study offers rare long-term analysis of techniques for creating standing dead trees for wildlife habitat

2024-01-23
CORVALLIS, Ore. – Ecologists have long known that standing dead trees, commonly referred to as snags, are an important habitat element for forest dwellers and act as a driver of biodiversity. They’re so important that in some managed forests, snag creation is part of the conservation tool kit – i.e., crews sometimes convert a percentage of live trees into dead ones through techniques ranging from sawing off their tops to wounding their trunks to injecting them with disease-causing fungi. Until now, however, key questions had remained unanswered: How well do any of those techniques actually work over the long term? ...

Ochsner receives multiple 2023 Press Ganey Awards

2024-01-23
NEW ORLEANS – Ochsner Health has been named the winner of five awards from Press Ganey, a globally recognized analytics company offering healthcare experience solutions and services. These awards are part of Press Ganey’s annual ranking of the top hospitals and health systems in the country, according to performance in patient experience, employee experience, physician experience, clinical quality performance and consumer experience. “We’re honored to be recognized by Press Ganey for our excellence and compassion in caring for ...

Popular diabetes drug may also reduce the risk of severe liver disease

2024-01-23
Ozempic and other GLP1 agonists are associated with a reduced risk of developing cirrhosis and liver cancer in people with type 2 diabetes and chronic liver disease, according to a nationwide study from Karolinska Institutet in Sweden published in the journal Gut. GLP1 agonists like Ozempic reduce blood sugar levels and are mainly used to treat type 2 diabetes. However, as the drug also reduces appetite, it is now increasingly used to treat obesity and has become a popular weight-loss drug. Reduced risk of liver damage Results from early clinical trials also suggest that GLP1 agonists may reduce the risk of liver damage. Therefore, researchers at ...

New publication describes findings on cat evolution, to aid in future disease studies

New publication describes findings on cat evolution, to aid in future disease studies
2024-01-23
DENVER/Jan. 23, 2024 – Morris Animal Foundation-funded researchers have delved into various cat species' entire DNA sequence (genome), uncovering novel perspectives on domestic and wild cat evolution. This new work highlights distinct genetic changes and will be a critical tool for researchers investigating feline diseases and characteristics. This study, which led to the findings published in Nature Genetics, used cutting-edge genome sequencing and assembly technologies to generate a more comprehensive and complete cat genome assembly, providing fundamental information on the feline blueprint and aiding in advancements in feline medicine. "This ...

Liquid lithium on the walls of a fusion device helps the plasma within maintain a hot edge

Liquid lithium on the walls of a fusion device helps the plasma within maintain a hot edge
2024-01-23
Emerging research suggests it may be easier to use fusion as a power source if liquid lithium is applied to the internal walls of the device housing the fusion plasma. Plasma, the fourth state of matter, is a hot gas made of electrically charged particles. Scientists at the Department of Energy’s Princeton Plasma Physics Laboratory (PPPL) are working on solutions to efficiently harness the power of fusion to offer a cleaner alternative to fossil fuels, often using devices called tokamaks, which confine plasma using magnetic fields. “The purpose of these devices is to confine the energy,” said Dennis Boyle, a staff research physicist ...

Novel material facilitates measurement of concrete deterioration in buildings and other structures

Novel material facilitates measurement of concrete deterioration in buildings and other structures
2024-01-23
Concrete is an essential material in the construction industry, where it is fundamental to the foundations and structures of dwellings and office buildings, as well as roads, dams and bridges, among many other infrastructure projects. However, the service life of concrete is limited, and it must be monitored in order to guarantee the safety of these structures. To facilitate fast, low-cost, in-situ analysis that dispenses with the need to take samples to a laboratory, researchers at the University of São Paulo’s Physics Institute (IF-USP) in Brazil, in collaboration with colleagues at the University of Leuven in Belgium, have developed a luminescent material that reveals the presence ...

Gene expression atlas captures where ovulation can go awry

2024-01-23
ITHACA, N.Y. -- An interdisciplinary collaboration used a cutting-edge form of RNA tagging to map the gene expression that occurs during follicle maturation and ovulation in mice. The resulting atlas reveals a slew of previously unknown cellular and molecular interactions that drive ovulation, which is crucial for female fertility. The findings could prove pivotal for developing therapeutic treatments for infertility. The research, published Jan. 22 in Proceedings of the National Academy of Sciences, was ...

MU study shows blood pressure drug can reduce anxiety for people with autism

MU study shows blood pressure drug can reduce anxiety for people with autism
2024-01-23
A new study at the University of Missouri’s Thompson Center for Autism and Neurodevelopment found that propranolol, a medication that treats high blood pressure, can also help lower anxiety for kids and young adults with autism spectrum disorder (ASD). Given that some individuals with ASD tend to struggle with anxiety at a far greater rate than their neurotypical peers, the new finding can significantly help such individuals with ASD. David Beversdorf, a clinician at the Thompson Center, led the study, which involved 69 patients over a three-year span. Compared to a placebo group, the participants who received propranolol showed ...

Analysis of US Census survey data reveals uptick in anxiety and depression among women in states with trigger laws post-Dobbs abortion decision 

2024-01-23
An analysis of national survey data conducted by researchers at the Johns Hopkins Bloomberg School of Public Health found a small but statistically significant increase in self-reported anxiety and depression symptoms among respondents in states that banned abortion after the U.S. Supreme Court’s reversal of Roe v. Wade in June 2022 compared to respondents in states that did not enact bans.  The Dobbs decision, handed down on June 24, 2022, overturned the 1973 Roe v. Wade decision that made abortion a constitutionally protected right and returned the question of abortion regulation to individual states. The Dobbs decision ...

JMIR Publications prepares to celebrate 25 years of publishing digital health research

2024-01-23
(Toronto, January, 23, 2024) 2024 will mark the 25th anniversary for JMIR Publications, the leading open access digital health research publisher.  Founded in 1999 by Gunther Eysenbach, MD, MPH, FACMI,   chief executive officer and executive editor,  JMIR Publications has grown to now include 35 journals that have published over 52,000 papers that have garnered over 500,000 citations and millions of views from users around the world.   JMIR Publications functions as a hub for digital health research. With its reputation for high-quality ...

LAST 30 PRESS RELEASES:

McMaster researchers discover what hinders DNA repair in patients with Huntington’s Disease

Estrogens play a hidden role in cancers, inhibiting a key immune cell

A new birthplace for asteroid Ryugu

How are pronouns processed in the memory-region of our brain?

Researchers synthesize high-energy-density cubic gauche nitrogen at atmospheric pressure

Ancient sunken seafloor reveals earth’s deep secrets

Automatic speech recognition learned to understand people with Parkinson’s disease — by listening to them

Addressing global water security challenges: New study reveals investment opportunities and readiness levels

Commonly used drug could transform treatment of rare muscle disorder

Michael Frumovitz, M.D., posthumously honored with Julie and Ben Rogers Award for Excellence

NIH grant supports research to discover better treatments for heart failure

Clinical cancer research in the US is increasingly dominated by pharmaceutical industry sponsors, study finds

Discovery of 3,775-year-old preserved log supports ‘wood vaulting’ as a climate solution

Preterm births are on the rise, with ongoing racial and economic gaps

Menopausal hormone therapy use among postmenopausal women

Breaking the chain of intergenerational violence

Unraveling the role of macrophages in regulating inflammatory lipids during acute kidney injury

Deep underground flooding beneath arima hot springs: A potential trigger for the 1995 Kobe (Hyogo-Ken Nanbu) earthquake

Sharing biosignals with online gaming partners to enhance a mutual sense of social presence between complete strangers

ABM releases position statement on breastfeeding in emergency situations

Elucidating the mechanism underlying de novo membrane formation during gametogenesis

Sensors and devices guided by artificial intelligence for personalized pain medicine

Fruit juice offers a fresh take on kombucha

Sloth survival under threat due to climate change, new study finds

Research sheds light on large-scale cosmic structures

Untapped potential: Study shows how water systems can help accelerate renewable energy adoption

Clean energy transition: Increasing global equity with finance

Orbitronics: New material property advances energy-efficient tech

Firearm laws restricting large-capacity magazines effective in reducing child deaths in mass shootings

Black infants with heart abnormalities more likely to die in first year

[Press-News.org] Dirk Görlich receives Louis-Jeantet Prize for Medicine 2024
The scientist investigates how large molecules are transported between the cell nucleus and cytoplasm